N,N-Dimethylaniline

N,N-Dimethylaniline (DMA) replaces both hydrogens on aniline's amino group with methyl groups, giving a tertiary amine that is noticeably more basic than aniline itself but no longer able to participate in the diazotisation chemistry that defines most of the aniline-derivative products elsewhere in our range. We want to flag a genuine, worth-knowing tension in this compound's hazard data: the EU-harmonised classification includes H351 (suspected of causing cancer, Carc. 2), while IARC evaluated this substance (Monograph Volume 57, 1993) and placed it in Group 3 — not classifiable as to carcinogenicity to humans. These aren't necessarily in conflict — the EU evaluation is more recent and uses CLP's own self-classification framework — but we report both findings rather than letting the older, more reassuring IARC finding stand alone.

Commercially, this compound has two well-documented identities: as a dye intermediate feeding triarylmethane dye chemistry (malachite green, crystal violet, and related dyes), and as a widely used accelerator/promoter in the curing of polyester and vinyl-ester resins and in acrylic (PMMA) polymerisation chemistry — including, as general chemical-industry literature widely documents, dental and bone-cement applications, though we'd note this specific application wasn't independently re-sourced in the research behind this page beyond what is well-established general knowledge in the field.

Where it fits in the synthesis chain

We supply N,N-Dimethylaniline itself. We do not manufacture or supply the finished dyes, resins, or cured products made using it as an intermediate or accelerator.

Grades we supply

98.5% and 99%+ grades are both seen across the trade.

N,N-Dimethylaniline is made industrially by N-alkylation of aniline with methanol, under acid catalysis and elevated temperature and pressure — dimethyl ether can substitute as the methylating agent in some processes.

The reaction is run to favour complete dimethylation over the mono-methyl intermediate (N-methylaniline), since the tertiary amine is the commercially required product; reaction conditions and methanol stoichiometry are tuned accordingly.

The crude product is purified by distillation to separate it from unreacted aniline, the mono-methyl intermediate, and any ring-methylated by-products, then tested for purity and colour before release.

A genuine tension in the carcinogenicity data, stated plainly

IARC's 1993 evaluation (Group 3, not classifiable) and the EU's harmonised CLP classification (Carc. 2, suspected) look like they disagree, and in a sense they do — but not because one is wrong. IARC's review is older and assessed the evidence available at that time against IARC's own evidentiary framework; the EU's classification reflects CLP's self-classification process, which can and does reach different conclusions on the same underlying data using different criteria and, in some cases, more recent information. We report both findings rather than quietly picking the more reassuring one.